Telehealth tDCS to reduce cannabis use: A pilot RCT in multiple sclerosis as a framework for generalized use
Pilloni et al., 2025. Drug and Alcohol Dependence
This pilot randomized controlled trial tested home-based, remotely supervised tDCS combined with mindfulness meditation for cannabis use disorder in women with multiple sclerosis.
- Design: A double-blind trial with 47 women with MS and cannabis use disorder, randomized 2:1 to active or sham tDCS.
- Treatment: 20 home sessions over four weeks at 2 mA for 20 minutes over the left dorsolateral prefrontal cortex. Each session was paired with guided meditation and supervised over live video.
- Main result: In the active group, cannabis use fell from 5.3 to 3.9 days per week and withdrawal symptoms decreased. There was no significant change in the sham group.
- Adherence: 83% completed the intervention, and no one dropped out because of the treatment.
CONCLUSION: Telehealth tDCS appears feasible and shows early promise for reducing cannabis use, which supports testing it in larger trials.